Stockreport

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases [Yahoo! Finance]

InflaRx N.V.  (IFRX) 
Last inflarx n.v. earnings: 8/14 04:05 pm Check Earnings Report
PDF targeting the complement system, today announced the presentation of preclinical data for the company's novel oral C5aR inhibitor, INF904, at the 2024 European Meeting o [Read more]